NCT05393856 - CG-549 Tablet Pharmacokinetics Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

January 20, 2020

Study Completion Date

June 30, 2020

Conditions

Healthy

Interventions

DRUG

CG-549

"PART A (open-label)~Period 1: single oral dose. Period 2: After PK evaluation of period 1. Period 3: After PK evaluation of period 2.~PART B (randomized)~* Period 1: a single oral dose of ZZ mg CG-549 on Day 1 in fed or fasted state.~* Period 2: a single oral dose of ZZ mg CG-549 on Day 1 in fasted or fed state."

Trial Locations (1)

Unknown

PRA Health Sciences (PRA) - Early Development Services (EDS), Groningen